Last Price$59.76.8%
Market Cap$3,532.4M
1Y Forward Revenue growth
(77.0%)
1Y Forward EPS growth
N/A
Last EPS & EPS Surprise
$2.14
54.1% beat
Last 10 Earnings
10 Beat / 0 Miss
PTGX Revenue and EPS Expectations
Annual
Quarterly
| Dec'22 | Dec'23 | Dec'24 | Dec'25 | Dec'26 | Dec'27 | Dec'28 | Dec'29 | |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | (2.8%) | 125.7% | 624.1% | (77.0%) | 37.0% | 5.0% | 100.4% | 80.9% |
| EPS growth | (4.9%) | (44.8%) | N/A | N/A | (22.0%) | (2.8%) | N/A | 908.3% |
PTGX Earnings Surprises
Crunching data... Almost there!
PTGX Earnings History
| Mar'15 | Jun'15 | Sep'15 | Dec'15 | Mar'16 | Jun'16 | Sep'16 | Dec'16 | Mar'17 | Jun'17 | Sep'17 | Dec'17 | Mar'18 | Jun'18 | Sep'18 | Dec'18 | Mar'19 | Jun'19 | Sep'19 | Dec'19 | Mar'20 | Jun'20 | Sep'20 | Dec'20 | Mar'21 | Jun'21 | Sep'21 | Dec'21 | Mar'22 | Jun'22 | Sep'22 | Dec'22 | Mar'23 | Jun'23 | Sep'23 | Dec'23 | Mar'24 | Jun'24 | Sep'24 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue actual | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $8,781.0K | $11.3M | $10.8M | $11.7M | $6,117.0K | $2,353.0K | $1,560.0K | ($8,189.0K) | $4,141.0K | $2,719.0K | $3,647.0K | $6,217.0K | $13.1M | $5,650.0K | $6,189.0K | $2,265.0K | $10.3M | $8,617.0K | $25.7M | $859.0K | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $60.0M | $255.0M | $4,167.0K | $4,675.0K | $170.6M |
| Revenue estimate | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $8,684.7K | $8,684.7K | $8,684.7K | $8,684.7K | $4,894.6K | $11.2M | $4,826.5K | $4,227.8K | $1,480.0K | $2,950.0K | $2,866.7K | $2,700.0K | $1,500.0K | $5,171.4K | $1,742.9K | $5,071.4K | $21.2M | $460.0K | $460.0K | $3,333.3K | $2,000.0K | $2,000.0K | $2,000.0K | $60.0M | $262.5M | $3,141.8K | $3,112.5K | $132.4M |
| Revenue surprise | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 24.1% | 34.4% | 29.6% | 72.9% | 68.1% | 173.1% | 14.2% | 35.7% | 146.4% | 110.7% | 357.5% | 109.3% | 312.6% | 56.2% | 490.2% | 69.9% | 21.4% | 86.7% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 0.0% | 2.9% | 32.6% | 50.2% | 28.9% |
| EPS actual | ($0.46) | ($0.55) | ($0.59) | ($0.93) | ($2.00) | ($0.43) | ($0.84) | ($0.67) | ($0.84) | ($0.89) | ($0.29) | ($0.15) | ($0.36) | ($0.41) | ($0.38) | ($0.57) | ($0.58) | ($1.18) | ($0.61) | ($0.63) | ($0.72) | ($0.59) | ($0.21) | ($0.48) | ($0.54) | ($0.69) | ($0.70) | ($0.77) | ($0.43) | ($0.83) | ($0.62) | ($0.64) | ($0.62) | ($0.68) | ($0.58) | $0.45 | $3.41 | ($0.50) | ($0.54) | $2.14 |
| EPS estimate | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ($0.22) | ($0.22) | ($0.22) | ($0.22) | ($0.59) | ($0.28) | ($0.71) | ($0.65) | ($0.69) | ($0.57) | ($0.61) | ($0.48) | ($0.57) | ($0.55) | ($0.67) | ($0.78) | ($0.54) | ($0.94) | ($0.94) | ($0.67) | ($0.73) | ($0.73) | ($0.73) | $0.05 | $3.37 | ($0.60) | ($0.58) | $1.39 |
| EPS surprise | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 63.6% | 86.4% | 72.7% | 159.1% | 1.0% | 321.4% | 13.7% | 2.8% | 4.0% | 4.4% | 65.7% | 0.4% | 4.9% | 26.5% | 4.5% | 1.5% | 20.4% | 11.3% | 33.7% | 4.2% | 14.6% | 6.4% | 20.1% | 739.3% | 1.3% | 16.0% | 6.5% | 54.1% |
FAQ
1. What is Protagonist Therapeutics, Inc. (PTGX) 1-year forward revenue growth estimate?
Protagonist Therapeutics, Inc. (PTGX) 1-year forward revenue growth is estimated at (77.0%).
2. What is Protagonist Therapeutics, Inc. (PTGX) 1-year forward EPS growth estimate?
Protagonist Therapeutics, Inc. (PTGX) 1-year forward EPS growth is estimated at N/A.
3. What was Protagonist Therapeutics, Inc. (PTGX) last EPS, and was there a surprise?
Protagonist Therapeutics, Inc. (PTGX) last reported EPS was $2.14, with a 54.1% beat.
4. What is Protagonist Therapeutics, Inc. (PTGX) performance across the last 10 earnings reports?
Protagonist Therapeutics, Inc. (PTGX) had 10 beats and 0 misses in its last 10 earnings reports.